How do we develop nanopharmaceuticals under open innovation?
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering
Reference12 articles.
1. Nanomedicine: industry-wise research;Eaton;Nat Mater,2007
2. Ackland G. Patent WO 2008/001053 A1 2008.
3. Ackland G, Gourine A. Patent WO 2008/001055 A1.
4. The PEG moiety of certolizumab pegol is rapidly cleared from the blood of humans by the kidneys once it is cleaved from the Fab’;Parton;Inflamm Bowel Dis,2009
5. Reappraisal of disparities between osmolality estimates by freezing point depression and vapor pressure deficit methods;Winzor;Biophys Chem,2004
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polysaccharide-based nanoassemblies: From synthesis methodologies and industrial applications to future prospects;Advances in Colloid and Interface Science;2023-08
2. Nanomedicines: Nano based Drug Delivery Systems Challenges and Opportunities;Alternative Medicine - Update;2021-10-27
3. On risks and benefits of nanotechnology: the case of medical applications;Handbook of Functionalized Nanomaterials;2021
4. Prolonged release of metformin by SiO2 nanoparticles pellets for type II diabetes control;European Journal of Pharmaceutical Sciences;2019-04
5. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities;Nanomedicine;2019-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3